Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

Launched by ALTAMASH INSTITUTE OF DENTAL MEDICINE · Mar 30, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different materials used in a dental treatment called pulpotomy, which is done on mature permanent teeth that have been damaged by deep cavities. The materials being compared are MTA (mineral trioxide aggregate) and Biodentin. Researchers want to see if using Biodentin will lead to better outcomes for patients, meaning a higher success rate in treating teeth that have been exposed to decay.

To participate in this study, you need to have mature permanent teeth that require treatment, but you can't have any restorations (like fillings) already placed in those teeth. The trial is not yet recruiting participants, but it aims to include individuals aged 6 to 74. If you take part, you can expect to be treated with one of the two materials and monitored for how well the treatment works. This study is important because it could help improve dental care for people with serious tooth issues caused by decay.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • mature permanent teeth
• Exclusion Criteria:
• • Teeth with restorations